Related Experiment Videos
Prospects for B-cell-targeted therapy in autoimmune disease
1University College London Centre for Rheumatology, UK.
Rheumatology (Oxford, England)
|October 29, 2004
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
B cell phenotypes in patients with rheumatoid arthritis relapsing after rituximab: expression of B cell-activating factor-binding receptors on B cell subsets.
Clinical and experimental immunology·2017
Extended B cell phenotype in patients with myalgic encephalomyelitis/chronic fatigue syndrome: a cross-sectional study.
Clinical and experimental immunology·2015
Effect of rituximab on B cell phenotype and serum B cell-activating factor levels in patients with thrombotic thrombocytopenic purpura.
Clinical and experimental immunology·2014
Clinical outcome following B cell depletion therapy in eight patients with refractory idiopathic inflammatory myopathy.
Clinical and experimental rheumatology·2008
Subcutaneous versus intravenous ultra-low dose rituximab in rheumatoid arthritis: a randomised controlled PK-PD non-inferiority trial.
Rheumatology (Oxford, England)·2026
Early-life dietary patterns and the risk of juvenile-onset ankylosing spondylitis: a nationwide cohort study in South Korea.
Rheumatology (Oxford, England)·2026
TMEM176B is co-expressed with TMEM176A and upregulated in peripheral blood monocytes of patients with primary Sjögren's syndrome.
Rheumatology (Oxford, England)·2026
Early longitudinal proteomic changes during sirolimus therapy in tocilizumab-refractory idiopathic multicentric Castleman disease.
Rheumatology (Oxford, England)·2026
Mediterranean diet and health outcomes in idiopathic inflammatory myopathies.
Rheumatology (Oxford, England)·2026
Bimekizumab efficacy in male and female patients with axial spondyloarthritis: 52-week results from the Phase 3 BE MOBILE rials.
Rheumatology (Oxford, England)·2026
Pulmonary Light Chain Deposition Disease in a Patient With Chronic Lymphocytic Leukemia.
International journal of surgical pathology·2026
Tislelizumab-induced hyperamylasemia: Case report and safety analysis using the FAERS database.
International journal of clinical pharmacology and therapeutics·2026
Artifact-suppressed dual-modality OCT-fluorescence endoscopic imaging of colitis in murine models.
Biomedical optics express·2026